Post-ERCP pancreatitis: Risk stratification and appropriate patient selection

Since the advent of endoscopic retrograde cholangiopancreatography (ERCP) over 4 decades ago, the endoscopic management of pancreaticobiliary disease has fundamentally changed [1]. While ERCP was initially used as a diagnostic and therapeutic tool, advances in noninvasive imaging modalities, primarily magnetic resonance cholangiopancreatography (MRCP) and endoscopic ultrasound (EUS), have made ERCP an exclusively therapeutic procedure.

Source: Techniques in Gastrointestinal Endoscopy - October 9, 2014 Category: Gastroenterology Authors: Robert A. Moran, Venkat S. Akshintala, Vikesh K. Singh Source Type: research